FindTrial
Sign In

Comparison of effect of Atorvastatin and Rosuvastatin on Lipid Profile and Vitamin D concentration in patients with abnormal lipid level.

A comparative study to evaluate the impact of Atorvastatin versus Rosuvastatin on the Lipid profile and Vitamin D concentration in Dyslipidemic patients of eastern Uttar Pradesh population - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061941
Enrollment
128
Registered
2024-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: Rosuvastatin: 10 mg OD for 3 months Control Intervention1: Atorvastatin: 20 mg OD for 3 months

Sponsors

Dr Ashutosh Roy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients giving written informed consent for the study. Both genders. All patients 25 years of age with dyslipidaemia not meeting the goal for LDL-C, according to the European Society of Cardiology (ESC) and the European Atherosclerosis Society guidelines for the management of dyslipidaemias. All adult patients age (25-65 years) willing to take medication as directed and ready to come for the follow up.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Quality of lifeTimepoint: Base line, 1st month, 2nd month, 3rd month—

Secondary

MeasureTime frame
Lipid profile, Vitamin D Concentration, Adverse drug reaction.Timepoint: Every month for 3 month—

Countries

India

Contacts

Public ContactDr Anil Kumar

B R D Medical College

dranilk194@gmail.com8303060884

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026